Overview
Obligated since award on contracts active FY2021–FY2026
Click a company to open its profile.
Insight CDC OFFICE OF ACQUISITION SERVICES (75D301) is its largest buyer. See more on the Buyers tab
Agencies report with a delay; the latest year will rise
Hover over a year to see its value.
Insight Largest year: $28.5K in FY2024. See more on the Contracts tab
$47.5K since award = $28.5K in FY2021–FY2026 + $19K before FY2021
Click a state to open its page.
Insight 60% was performed in Georgia. See more on the Contracts tab
Contracts
2 contracts with an action since FY2021
Click a bar to open its contract.
Insight Stand-alone contracts hold 100% of these contracts' obligations.
Gold Biotechnology Inc. prime contracts with an action in FY2021–FY2026
Find a contract by vehicle, office or end date; sort by money to see the largest.
0 end within 12 months.
Showing 1–2 of 2 contracts
| Since award, US$ | |||||
|---|---|---|---|---|---|
| Parent contract (IDVIDV: the record type for any contract that exists to take orders: IDIQs, GWACs, GSA Schedules, BPAs and basic ordering agreements. Glossary) | ObligatedObligation: money the government has legally committed to a contract. It is not the same as money paid. Example: $6M obligated of a $10M ceiling. Glossary | ||||
| 75D30124P18906 | Stand-alone | CDC OFFICE OF ACQUISITION SERVICES (75D301) | $28,543 | Sep 30, 2024 | Ended |
| W81XWH18P0212 | Stand-alone | W4PZ USA MED RSCH ACQUIS ACT (W81XWH) | $18,960 | Jun 15, 2021 | Ended |
Buyers
Centers for Disease Control and Prevention: $28.5K obligated since award; $28.5K in FY2021–FY2025 actions
Click a bar to open its office page.
Insight Centers for Disease Control and Prevention placed 60%.
Contracting offices that awarded Gold Biotechnology Inc. prime contracts, FY2021–FY2026
See which offices award its contracts.
2 offices awarded only one contract.
Showing 1–2 of 2 offices
| Contracts active FY2021–FY2026; obligated since award, US$ | |||||
|---|---|---|---|---|---|
| CDC OFFICE OF ACQUISITION SERVICES (75D301) | Centers for Disease Control and Prevention | 1 | $28,543 | Aug 21, 2024 | Aug 21, 2024 |
| W4PZ USA MED RSCH ACQUIS ACT (W81XWH) | Department of the Army | 1 | $18,960 | Sep 22, 2018 | Dec 14, 2020 |
Opportunities
Open opportunities matching Gold Biotechnology Inc.'s registered industries
Notices in its 2 industries (NAICSNAICS code: a six-digit code for the kind of work a company does. Each contract carries one, and it sets the small-business size limit. Glossary): 325414, 424690
3 of the next 3 are due within 30 days.
Showing 1–3 of 3 opportunities
| Opportunity | Agency | Due |
|---|---|---|
| PANDHA-26-P-0000 046638 Defibrinated Rabbit Blood (opens in Procura)Special Notice · NAICS 325414Free account: full notice, dates, attachments | Defense Health Agency (DOD) | Oct 23, 2026 |
| Brand Name - Dectomax (Doramectin) 500mL Injectable Solution (opens in Procura)Combined Synopsis/Solicitation · Set aside: Small business · NAICS 325414Free account: full notice, dates, attachments | Animal and Plant Health Inspection Service (USDA)MRPBS MINNEAPOLIS MN (126395) | Oct 30, 2026 |
| Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC) (opens in Procura)Combined Synopsis/Solicitation · NAICS 325414Free account: full notice, dates, attachments | Animal and Plant Health Inspection Service (USDA)MRPBS MINNEAPOLIS MN (126395) | Nov 10, 2026 |
Registration and contacts
Registration
- UEI
- R1TBUKSMRM49
- CAGE code
- 0TMT0
- Registration
- Active, expires Jul 31, 2027
- Entity type
- Corporate Entity (Not Tax Exempt)
- Location
- SAINT LOUIS, MO, 63132
- Congressional district
- MO-01
Registered industries (NAICSNAICS code: a six-digit code for the kind of work a company does. Each contract carries one, and it sets the small-business size limit. Glossary)
Registered in 2 industries; primary 325414
Contacts at Gold Biotechnology Inc.
| Contact | Role | As of |
|---|---|---|
| See contactsLocked · 7-day trial or paid plan (name, title and contact details with a 7-day trial or paid plan) | Company contactSBA profileAs of Oct 4, 2026 | Oct 4, 2026 |
Correct this listing
Tell us what to correct or add on the Gold Biotechnology Inc. page. We check every request before we change a profile.